Subscribe

DCI Blog

All
All

Duke Cancer Institute (DCI) Blog provides updates, organizational announcements, the latest in funding opportunities and information on upcoming conferences and symposiums. This blog also highlights inspiring patient stories and the accomplishments and achievements of DCI faculty and staff. Subscribers are invited to submit story ideas and other news of interest. Email submissions and feedback to Karen E. Butler, Director of Communications, Duke Cancer Institute.

Cancer Centers Invited To Participate In Hill Day (4.30.19)

The Association of American Cancer Institutes (AACI) and American Association for Cancer Research (AACR) annual Hill Day will take place in Washington, DC, on Tuesday, April 30. Participation in Hill Day is critical to sharing that stable, predictable funds are needed to advance cancer research and...

NCCU & Duke Students Learn Mentor-Mentee Communication Skills

On Wednesday, February 27, a cohort of six graduate students from Duke and six from North Carolina Central University plus one postdoctoral fellow from each school — gathered for a mentor-mentee communications workshop — the third in a series of trainings designed to engage underrepresented...

Genomic Testing Associated with Significantly Lower Health Care Costs in High-Risk Breast Cancer Patients

New research from Duke University, published in the March 2019 issue of JNCCN—Journal of the National Comprehensive Cancer Network , provides evidence that genomic recurrence score (RS) testing using the 21-gene assay is associated with decreased cancer care costs in real-world practice among...

Famiglietti Appointed DCI Chief Administrator

Robin Famiglietti, PhD, MBA, FACHE, has been appointed chief administrator of Duke Cancer Institute and associate vice president of Oncology Services for Duke University Health System (DUHS). "We are confident that Dr. Famiglietti’s experience, expertise and commitment qualified her as the best...

Devi named to ACTS board of Directors

Gayathri Devi , PhD associate professor of surgery and pathology and director of Duke Cancer Institute's Consortium for Inflammatory Breast Cancer , has been elected to serve on Association for Clinical and Translational Sciences (ACTS) board of directors (2019-2020). "It is my pleasure to welcome...

March Newsmakers

Read here for a sample of some of the DCI physicians, physician-scientists, researchers and nurses whose work is featured in the media and academic journals this month. This list features Andrew Armstrong, MD; Niharika Mettu, MD; John Strickler, MD; Michael Morse, MD; and many more.

Komen Race For The Cure

The 23rd Annual Susan G. Komen Triangle Race for the Cure, presented locally by Duke Cancer Institute, will take place on Saturday, May 4, at The Frontier in Research Triangle Park (RTP). The Race attracts thousands of participants, many of whom are survivors and individuals living with metastatic...

Once Upon A Time

The Lung Cancer Initiative of NC will host its annual Evening of Hope Gala, Once Upon A Time , on Saturday, April 27, at North Ridge Country Club in Raleigh, North Carolina. last year's gala raised $132,500 to help support lung cancer research in North Carolina. The Lung Cancer Initiative of North...

Ready, Set, CRUSH!

Colorectal cancer is the fourth most common cancer diagnosed in men and in women and the second leading cause of cancer death in the U.S. says the American Cancer Society. One in 22 men and one in 24 women will be diagnosed with colorectal cancer in their lifetime. The Duke Cancer Institute...

Blood Tests Predict Effectiveness of Hormonal Therapies

A multi-institutional group of clinical researchers, led by the Duke Cancer Institute’s Andrew Armstrong, MD, McS, FACP, published a new report this month in the Journal of Clinical Oncology , that describes results from the PROPHECY study, which prospectively compared two blood tests to assess how...

Vaccine for HER2 Breast Cancer Shows Early Promise

A vaccine developed by Duke Cancer Institute researchers has shown early promise in targeting the HER2 protein that fuels a deadly form of breast cancer. In a phase 1 clinical trial that enrolled 22 women with recurrent cancers that overexpress the HER2 protein, the vaccine demonstrated an ability...

Metastatic Cancer Survivor Dismisses Fear; Embraces “Eye Of The Tiger”

As an industrial engineer, Tom Vibert, 56, has excelled in his career by identifying waste and streamlining production processes; all the while, without jeopardizing quality. It’s no surprise then that when diagnosed with stage 4 metastatic colon cancer, Vibert dismissed the emotions that didn't...

Pages